Evaluation of the Alteration in Glucose Production and Metabolism Following Magnesium Usage among Diabetics

George Gborienemi Simeon; Gloria Ogbede

doi:10.59573/emsj.7(6).2023.13

Авторы

George Gborienemi Simeon
Gloria Ogbede

DOI:

https://doi.org/10.59573/emsj.7(6).2023.13

Ключевые слова:

Glucose, Production, Metabolism, Magnesium, Diabetics

Аннотация

The study aimed at evaluating the outcome on glucose concentration in some diabetics after measured dose of magnesium has been dispensed for 8 weeks duration. Applying various spectrophotometric methods, the concentration of glucose, glucagon, insulin and C-peptide were measured along with hepatic glucose production and rate of glucose infusion. Values from these parameters were statistically determined. We observed increase in both usage and metabolism following the administration of magnesium. We particularly observed insulin-induced reduction, total body glucose utilization (30.8 ± 0.7 Vs 36.5 ± 0.9 mol/ kg. min. P 0.005) and glucose metabolism (19.0 ± 0.8 Vs 23.2 ± 0.3 mol/ kg. min P 0.01) were raised after magnesium use. It is our conclusion that the use of magnesium at recommended dose could ameliorate glucose metabolism and enhance insulin sensitivity among diabetics.

Библиографические ссылки

Black, S., Kushner, I., & Samols, D. (2004). C-reactive protein. Journal of Biological Chemistry, 279(47), 48487-48490. Doi: 10.1074/jbc.R400025200

Chaudhary, D. P., Sharma, R., & Bansal, D. D. (2010). Implications of magnesium deficiency in type 2 diabetes: a review. Biological Trace Element Research, 134, 119-129. Doi: 10.1007/512011-009.8465-2

Curry, J. N., & Alan, S. L. (2018). Magnesium handling in the kidney. Advances in Chronic Kidney Disease, 25(3), 236-243. Doi: 10.1053/J.ackd.2018.01.003

Dzúrik, R., Stefíková, K., Spustová, V., & Fetkovská, N. (1991). The role of magnesium deficiency in insulin resistance: an in vitro study. Journal of Hypertension, 9, S312-S313.

Fapohunda, O., & Balogun, O. (2019). Oral magnesium supplementation modulates hepatic and intestinal expression of some carbohydrate metabolizing genes in type 2 diabetic rats. Int J Mol Biol Open Access, 4(6), 189-194. Doi: 10. 15406/imboa.2019.04.00119

Feng, J., Wang, H., Jing, Z., Wang, Y., Cheng, Y., Wang, W., & Sun, W. (2020). Role of magnesium in type 2 diabetes mellitus. Biological Trace Element Research, 196, 74-85. Doi: 10.1007/S12011-019-01922-0

Hardy, S., Kostantin, E., Wang, S. J., Hristova, T., Galicia-Vázquez, G., Baranov, P. V., ... & Tremblay, M. L. (2019). Magnesium-sensitive upstream ORF controls PRL phosphatase expression to mediate energy metabolism. Proceedings of the national academy of sciences, 116(8), 2925-2934. Doi: 10:1073/pna.1815361116

Hruby, A., Guasch-Ferré, M., Bhupathiraju, S. N., Manson, J. E., Willett, W. C., McKeown, N. M., & Hu, F. B. (2017). Magnesium intake, quality of carbohydrates, and risk of type 2 diabetes: results from three US cohorts. Diabetes Care, 40(12), 1695-1702. Doi: 10.2337/dc17-1143.

Kim, D. J., Xun, P., Liu, K., Loria, C., Yokota, K., Jacobs Jr, D. R., & He, K. (2010). Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care, 33(12), 2604-2610. Doi: 10.2337/dc10-0994

Limaye, C. S., Londhey, V. A., Nadkart, M. Y., & Borges, N. E. (2011). Hypomagnesemia in critically ill medical patients. The Journal of the Association of Physicians of India, 59, 19-22.

Meigs, J. B., Rutter, M. K., Sullivan, L. M., Fox, C. S., D'Agostino Sr, R. B., & Wilson, P. W. (2007). Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care, 30(5), 1219-1225. Doi: 10.2337/dco6-2484.

Mooren, F. C., Krüger, K., Völker, K., Golf, S. W., Wadepuhl, M., & Kraus, A. (2011). Oral magnesium supplementation reduces insulin resistance in non‐diabetic subjects–a double‐blind, placebo‐controlled, randomized trial. Diabetes, Obesity and Metabolism, 13(3), 281-284. Doi: 10.111/j.1463.1326.2010.01332X

Quamme, G. A., & Dai, L. J. (1990). Presence of a novel influx pathway for Mg2+ in MDCK cells. American Journal of Physiology-Cell Physiology, 259(3), C521-C525. Doi: 10.1152/ajocell.1990.259.3c521.

Rao, Y. S., & Rao, V. D. (2016). Serum magnesium levels in type 2 diabetes. Int J Res Med Sci, 4, 991-994. Doi: 10.18203/2320.6012ijrms20160682

Resnick, L. M., Gupta, R. K., Gruenspan, H., Alderman, M. H., & Laragh, J. H. (1990). Hypertension and peripheral insulin resistance: possible mediating role of intracellular free magnesium. American Journal of Hypertension, 3, 373-379.

Rodriguez-Moran, M. & Guerrero-Romero, F. (2008). Serum Magnesium and C-Reactive Protein levels. Arch Dis. Child, 93, 676-680. Doi: 10.1136/adc.2006.109371

Simmons, D., Joshi, S., & Shaw, J. (2010). Hypomagnesaemia is associated with diabetes: Not pre-diabetes, obesity or the metabolic syndrome. Diabetes Research and Clinical Practice, 87(2), 261-266. Doi: 10.1016/J.DIABRES.2009.11.003

Sohrabipour, S., Sharifi, M. R., Sharifi, M., Talebi, A., & Soltani, N. (2018). Effect of magnesium sulfate administration to improve insulin resistance in type 2 diabetes animal model: using the hyperinsulinemic‐euglycemic clamp technique. Fundamental & Clinical Pharmacology, 32(6), 603-616.

Togiello, L. (1996). Hypomagnesemia and Diabetes Mellitus. A review of clinical implications. Arch Intern Med., 156, 1143-8. Doi: 10.1001/archintel156.11.1143

Veronese, N., Watutantrige-Fernando, S., Luchini, C., Solmi, M., Sartore, G., Sergi, G., ... & Stubbs, B. (2016). Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and meta-analysis of double-blind randomized controlled trials. European Journal of Clinical Nutrition, 70(12), 1354-1359. Doi: 10.1038/ejen.2016.154